Carlsquare Equity Research comments on the news that NOSA intends to acquire PharmaCure, the original distributor of Nozoil, for a price of SEK 27.2 million on a debt and cash-free basis. The acquisition is pending approval of a Foreign Direct Investment (FDI) application as well as sufficient money being raised through an Accelerated Book Building (ABB) scheme.